These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 12481899)

  • 1. Antisense oligonucleotides complementary to Bax transcripts reduce the susceptibility of B-cell chronic lymphocytic leukaemia cells to apoptosis in a bcl-2 independent manner.
    Pepper C; Thomas A; Hoy T; Bentley P
    Leuk Lymphoma; 2002 Oct; 43(10):2003-9. PubMed ID: 12481899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl-2 antisense oligonucleotides enhance the cytotoxicity of chlorambucil in B-cell chronic lymphocytic leukaemia cells.
    Pepper C; Hooper K; Thomas A; Hoy T; Bentley P
    Leuk Lymphoma; 2001 Jul; 42(3):491-8. PubMed ID: 11699414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antisense-mediated suppression of Bcl-2 highlights its pivotal role in failed apoptosis in B-cell chronic lymphocytic leukaemia.
    Pepper C; Thomas A; Hoy T; Cotter F; Bentley P
    Br J Haematol; 1999 Dec; 107(3):611-5. PubMed ID: 10583267
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chlorambucil resistance in B-cell chronic lymphocytic leukaemia is mediated through failed Bax induction and selection of high Bcl-2-expressing subclones.
    Pepper C; Thomas A; Hoy T; Bentley P
    Br J Haematol; 1999 Mar; 104(3):581-8. PubMed ID: 10086798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity.
    Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
    Clin Cancer Res; 2003 Jul; 9(7):2856-65. PubMed ID: 12855666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced oxaliplatin-induced apoptosis following antisense Bcl-xl down-regulation is p53 and Bax dependent: Genetic evidence for specificity of the antisense effect.
    Hayward RL; Macpherson JS; Cummings J; Monia BP; Smyth JF; Jodrell DI
    Mol Cancer Ther; 2004 Feb; 3(2):169-78. PubMed ID: 14985457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated Bcl-2/Bax are a consistent feature of apoptosis resistance in B-cell chronic lymphocytic leukaemia and are correlated with in vivo chemoresistance.
    Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 1998 Jan; 28(3-4):355-61. PubMed ID: 9517506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisense oligodeoxynucleotides to bax mRNA promote survival of rat sympathetic neurons in culture.
    Gillardon F; Zimmermann M; Uhlmann E; Krajewski S; Reed JC; Klimaschewski L
    J Neurosci Res; 1996 Mar; 43(6):726-34. PubMed ID: 8984202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance.
    Thomas A; El Rouby S; Reed JC; Krajewski S; Silber R; Potmesil M; Newcomb EW
    Oncogene; 1996 Mar; 12(5):1055-62. PubMed ID: 8649796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoid-induced apoptosis in B-cell chronic lymphocytic leukaemia cells is mediated through caspase-3 activation and is independent of p53, the retinoic acid receptor, and differentiation.
    Pepper C; Ali K; Thomas A; Hoy T; Fegan C; Chowdary P; Kell J; Bentley P
    Eur J Haematol; 2002 Oct; 69(4):227-35. PubMed ID: 12431242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased apoptosis in B-chronic lymphocytic leukemia cells as a result of cyclin D3 down regulation.
    Wang P; Pavletic ZS; Joshi SS
    Leuk Lymphoma; 2002 Sep; 43(9):1827-35. PubMed ID: 12685840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flavopiridol circumvents Bcl-2 family mediated inhibition of apoptosis and drug resistance in B-cell chronic lymphocytic leukaemia.
    Pepper C; Thomas A; Hoy T; Fegan C; Bentley P
    Br J Haematol; 2001 Jul; 114(1):70-7. PubMed ID: 11472347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bcl-2 and bax expression and chlorambucil-induced apoptosis in the T-cells and leukaemic B-cells of untreated B-cell chronic lymphocytic leukaemia patients.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Res; 2000 Oct; 24(10):813-21. PubMed ID: 10996199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P53 mediates ceramide-induced apoptosis in SKN-SH cells.
    Kim SS; Chae HS; Bach JH; Lee MW; Kim KY; Lee WB; Jung YM; Bonventre JV; Suh YH
    Oncogene; 2002 Mar; 21(13):2020-8. PubMed ID: 11960374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bax antisense oligonucleotides reduce axotomy-induced retinal ganglion cell death in vivo by reduction of Bax protein expression.
    Isenmann S; Engel S; Gillardon F; Bähr M
    Cell Death Differ; 1999 Jul; 6(7):673-82. PubMed ID: 10453078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD6 ligation modulates the Bcl-2/Bax ratio and protects chronic lymphocytic leukemia B cells from apoptosis induced by anti-IgM.
    Osorio LM; De Santiago A; Aguilar-Santelises M; Mellstedt H; Jondal M
    Blood; 1997 Apr; 89(8):2833-41. PubMed ID: 9108402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between nitrogen mustard drug resistance in B-cell chronic lymphocytic leukemia (B-CLL) and protein expression of Bcl-2, Bax, Bcl-X and p53.
    Christodoulopoulos G; Fotouhi N; Krajewski S; Reed JC; Alaoui-Jamali M; Panasci L
    Cancer Lett; 1997 Dec; 121(1):59-67. PubMed ID: 9459175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal intracellular level of Bax in CD3+ cells from untreated B-cell chronic lymphocytic leukemia patients.
    Scamardella F; Maconi M; Albertazzi L; Gamberi B; Gugliotta L; Brini M
    Lab Hematol; 2006; 12(4):187-92. PubMed ID: 17118768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2, Bax and p53 expression in B-CLL in relation to in vitro survival and clinical progression.
    Aguilar-Santelises M; Rottenberg ME; Lewin N; Mellstedt H; Jondal M
    Int J Cancer; 1996 Apr; 69(2):114-9. PubMed ID: 8608978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.